Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Brivaracetam

Brivaracetam

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Brivaracetam

22 trials tracked of Brivaracetam: 13 in phase 3 or 4 and 12 with published results. The most-cited published study has 237 citations.

22Trials tracked
13Phase 3 & 4
0Recruiting
12With published results
Phase distribution
Phase 3 13 Phase 2 6 Phase 1 3
  1. Phase 3 Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures Completed · 237 cited
  2. Phase 3 Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy Completed · 236 cited
  3. Phase 3 Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures Completed · 230 cited
  4. Phase 3 Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy Completed · 161 cited
  5. Phase 3 Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV) Completed · 154 cited
  6. Phase 3 This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment Completed · 34 cited
Show 16 more trials
  1. Phase 3 Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy Completed · 25 cited
  2. Phase 3 An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam Completed · 25 cited
  3. Phase 3 Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy Completed · 25 cited
  4. Phase 3 Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy Completed · 25 cited
  5. Phase 3 A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization Completed · 1 cited
  6. Phase 3 A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy Completed
  7. Phase 3 Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Completed
  8. Phase 2 A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures. Completed
  9. Phase 2 A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With Epilepsy Completed
  10. Phase 2 A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia) Completed
  11. Phase 2 Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy. Completed
  12. Phase 2 A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting Completed
  13. Phase 2 Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury Completed
  14. Phase 1 A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Male Japanese Study Participants Completed
  15. Phase 1 A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil Completed
  16. Phase 1 A Study to Evaluate the Pharmacokinetics and Safety of Brivaracetam in Healthy Chinese Subjects Completed

Showing the 22 most-cited and recently-updated of 22 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.